Alternative mechanisms, such as post-transcriptional modulation of MGMT by miRNAs or the association of MGMT methylation with IDH mutation or the glioma CpG island methylator phenotype, may explain these inconsistent correlations and different outcomes. The gene discussed is MGMT; the disease is central nervous system cancer.